Purpose:To assess the safety and clinical outcomes of sutureless amniotic membrane (AM) transplantation in patients with small corneal perforations associated with severe ocular surface disease. Patients and Methods:This prospective observational study included 50 eyes of 50 patients with autoimmune or inflammatory ocular surface disease presenting with corneal perforations ≤3 mm. Under topical anesthesia, a double-layer AM was applied without sutures: one layer as a graft directly over the perforation and a second as a patch. A therapeutic contact lens and temporary eyelid closure were used; no topical medications were prescribed, while oral doxycycline (100 mg twice daily) was given for 15 days. Patients were examined at 1 week, 2 weeks, 1 month, 3 months, and 6 months. Primary outcomes were anatomical closure and corneal thinnest point (swept-source OCT). Secondary outcomes included complications and need for further surgery. Results:Complete anatomical closure was achieved in all cases (100%), with a mean healing time of 14.2 ± 3.6 days (range 9-21). Corneal thinnest point increased significantly from 215 ± 38 µm at baseline to 402 ± 39 µm at 6 months (p = 0.000031, repeated-measures ANOVA). No cases of AM displacement, secondary infection, intraocular complications, or re-intervention were observed. The procedure was well tolerated in all patients. Conclusion:Sutureless AM transplantation is a safe, minimally invasive, and effective option for managing ≤3 mm non-infectious corneal perforations in severe ocular surface disease. It enables rapid anatomical restoration, avoids suture-related inflammation, and may be particularly advantageous in fragile or immunocompromised patients.
Purpose:To investigate the differences in refractive status between children with autism spectrum disorders (ASD) and normal children, as well as the differences in the development of ocular characteristic parameters such as axial length(AL), in order to provide some help for eye care and subsequent rehabilitation in this group. Patients and Methods:This cross-sectional study enrolled 95 children aged 4-12 years with ASD from the Handan region of China, along with 96 matched control children. All participants underwent non-cycloplegic ocular refraction and ocular biometric parameter measurements, aiming to explore the association between ASD and ocular refractive errors as well as ocular biometric parameters. Results:Children with ASD exhibited significantly higher hyperopia, Spherical equivalent (SE: ASD 0.00 ±1.30 DS vs control -0.50 ±1.80 DS, p < 0.01), Cylinder (CYL: ASD -0.75 ±1.50DC vs control -0.50 ±0.50 DC, p < 0.01), shallower Anterior Chamber Depth (ACD) (ASD 2.93 ±0.26 vs control 3.03 ±0.34, p < 0.05) compared to controls. SE was negatively correlated with AL. The axial length-to-crane ratio (AL/CR), ACD, and vitreous thickness (VT) were positively correlated with lens thickness (LT) (p <0.05). Logistic regression analysis demonstrated that SE, CYL, AL/CR, and ACD were associated with ASD (all p-values <0.05). The random forest model indicated that SE (25.5%) and ACD (25.3%) were the primary predictors of ASD. Conclusion:The detection of ocular biological characteristic parameters has significant guiding significance for correcting refractive errors in children with ASD. Moreover, the combined diagnosis of SE, CYL, AL/CR, and may help identify children who may benefit from further ASD assessment. However, the predictive utility of these parameters requires validation in prospective, larger-scale studies.
Ziel der etagenweisen Revision ist eine einzeitige, idealerweise definitive chirurgische Therapie der Vorderkammerlinsen-bedingten Hornhaut-Endothel-Epithel-Dekompensation (HEED) und bullöser Keratopathie mittels Intraokularlinsen(IOL)-Explantation, Pars-plana-Vitrektomie, sekundärer IOL-Implantation und simultaner „Descemet membrane endothelial keratoplasty“ (DMEK). Voraussetzung für eine derartige Operation ist die Abwesenheit von prädescemetalen kornealen Narben. Für eine vollständige Mobilisation der subluxierten Vorderkammer-Iris-Claw-IOL werden die Haptiken durchtrennt, und die Linse wird durch einen 6 mm breiten, kranialen sklerokornealen Tunnel entfernt. Bei stattgehabter Kapselruptur (extern) erfolgte eine vordere und hintere 25-Gauge-Vitrektomie einschließlich aktiver hinterer Glaskörperabhebung. Nach manueller Irisdehnung zur bestmöglichen Rekonstruktion von Iris und Pupille wird eine Iris-Claw-IOL retroiridal enklaviert. Abschließend erfolgt eine DMEK mit Transplantatdurchmesser von 7,5 mm von temporal zur Therapie der Hornhautdekompensation. Bei Patienten mit Hornhaut-Endothel-Epithel-Dekompensation und bullöser Keratopathie durch eine (sub)luxierte Vorderkammer-IOL ist die IOL-Explantation mit kompletter Vitrektomie, sekundärer Implantation einer retroiridal irisfixierten IOL und kombinierter DMEK eine effektive, einzeitige chirurgische Therapieoption. Die Online-Version dieses Beitrags enthält ein Video.
Maura Mancini,1 Claudio Brancato,2 Alessandro Meduri,1 Gregorio Lo Giudice21Department of Biomedical Sciences, Ophthalmology Clinic, University of Messina, Messina, Italy; 2Department of Ophthalmology, ARNAS Civico Hospital, Palermo, ItalyCorrespondence: Maura Mancini, Email maura.mancini94@gmail.comIntroduction: Bilateral Acute Iris Transillumination (BAIT) is a rare ocular condition characterized by acute iris depigmentation, pigment dispersion in the anterior chamber, sphincter paralysis, and frequently elevated intraocular pressure. However, atypical presentations may occur, complicating diagnosis and expanding the clinical spectrum of the disease.Case Presentation: A 25-year-old woman presented with acute onset of severe photophobia associated with migraine and visual aura. Slit-lamp examination revealed bilateral diffuse 360° iris transillumination and nearly fixed atonic mydriasis, in the absence of pigment dispersion, anterior chamber inflammation, or intraocular pressure elevation. Systemic evaluation revealed recent respiratory illness and associated dermatologic manifestations. No ocular treatment was initiated due to the absence of inflammatory signs or ocular hypertension. Photophobia resolved spontaneously, while iris abnormalities persisted.Conclusion: This case suggests a possible pigment-negative or incomplete variant of BAIT, characterized by the absence of pigment dispersion and normal intraocular pressure. Recognition of such atypical presentations is essential to avoid misdiagnosis and unnecessary treatment, and may contribute to a broader understanding of the clinical spectrum and pathophysiology of BAIT.Keywords: bilateral acute iris transillumination, BAIT, iris transillumination, mydriasis, photophobia
Seit vielen Jahren stellt die Amnionmembrantransplantation (AMT) ein wichtiges Verfahren bei der Behandlung von persistierenden kornealen Epitheldefekten dar. Das Ziel dieser Studie war, den Einfluss systemischer Grunderkrankungen, der systemischen Begleitmedikation, des Hornhautstatus, der Art des Epitheldefekts sowie der Operationstechnik auf den Therapieerfolg zu beurteilen. Insgesamt wurden über den Zeitraum von 2013 bis 2019 780 AMT (496 Patienten, 519 Augen) retrospektiv untersucht. Zusätzlich wurden die systemische Begleiterkrankung (unterteilt in verschiedene Kategorien) und Begleitmedikation, die Tiefe des Defekts (Erosio/Ulkus), der Hornhautstatus (eigene Hornhaut [HH]/Transplantat [TPL]) und die Operationstechnik (Patch/Sandwich/Graft) erfasst. Die Zielgrößen waren der Epithelschluss nach 4 Wochen sowie die Rezidivrate. Der Nachbeobachtungszeitraum betrug ein Jahr. Später auftretende Misserfolge wurden nicht berücksichtigt. Das Signifikanzniveau betrug p ≤ 0,05. Es ergab sich eine Epithelschlussrate von 58,8